Cargando…

Free Insulin-like Growth Factor (IGF)-I in Children with PWS

In children with Prader–Willi syndrome (PWS), the standard growth hormone (GH) dose often results in high immunoreactive IGF-I levels. These high immunoreactive IGF-I levels lead to concern because their long-term effects are unknown. As a result, clinicians have to lower the GH dose, which worsens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Damen, Layla, Elizabeth, Melitza S. M., Donze, Stephany H., van den Berg, Sjoerd A. A., de Graaff, Laura C. G., Hokken-Koelega, Anita C. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911349/ https://www.ncbi.nlm.nih.gov/pubmed/35268371 http://dx.doi.org/10.3390/jcm11051280

Ejemplares similares

THU171 Reference Intervals For Bioavailable IGF-I Values In Dutch Healthy Children, Adolescents And Young Adults
por: Pellikaan, Karlijn, et al.
Publicado: (2023)

Long-Term Growth Hormone Treatment of Children with PWS: The Earlier the Start, the Better the Outcomes?
por: Grootjen, Lionne N., et al.
Publicado: (2022)

Case Report: A Detailed Phenotypic Description of Patients and Relatives with Combined Central Hypothyroidism and Growth Hormone Deficiency Carrying IGSF1 Mutations
por: Elizabeth, Melitza S. M., et al.
Publicado: (2022)

Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition
por: Damen, Layla, et al.
Publicado: (2020)

SAT-446 No Central Adrenal Insufficiency Found in Adults with Prader-Willi Syndrome Tested by Multiple-Dose Metyrapone Test
por: Davidse, Kirsten, et al.
Publicado: (2019)

Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin
por: Damen, Layla, et al.
Publicado: (2020)

Evidence for Accelerated Biological Aging in Young Adults with Prader–Willi Syndrome
por: Donze, Stephany H, et al.
Publicado: (2019)

Genetic screening of regulatory regions of pituitary transcription factors in patients with idiopathic pituitary hormone deficiencies
por: Elizabeth, Melitza, et al.
Publicado: (2017)

Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome
por: Donze, Stephany H., et al.
Publicado: (2019)

Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome
por: Bochukova, Elena G., et al.
Publicado: (2018)

Impact of Deprivation on Obesity in Children with PWS
por: Grolleau, Sabrina, et al.
Publicado: (2022)

Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium
por: Schwartz, Lauren, et al.
Publicado: (2021)

Congenital hypopituitarism in two brothers with a duplication of the ‘acrogigantism gene’ GPR101: clinical findings and review of the literature
por: Elizabeth, Melitza S. M., et al.
Publicado: (2020)

Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome
por: Grootjen, Lionne N., et al.
Publicado: (2022)

Topline Results of the CARE-PWS Phase 3 Study: Intranasal Carbetocin Improves Hyperphagia and Anxiety and Distress Symptoms in Prader-Willi Syndrome (PWS)
por: Ryman, Davis, et al.
Publicado: (2021)

ROHHAD and Prader-Willi syndrome (PWS): clinical and genetic comparison
por: Barclay, Sarah F., et al.
Publicado: (2018)

Perspectives of the European Society of Endocrinology (ESE) and the European Society of Paediatric Endocrinology (ESPE) on rare endocrine disease
por: Reincke, Martin, et al.
Publicado: (2021)

The GH/IGF-I axis in children with a meningococcal septic shock: striking differences between survivors and non-survivors
por: de Groof, F, et al.
Publicado: (2000)

Genetic analysis of IRF6, a gene involved in craniofacial midline formation, in relation to pituitary and facial morphology of patients with idiopathic growth hormone deficiency
por: Starink, Eline, et al.
Publicado: (2017)

Serum Levels of Free Insulin-Like Growth Factor (IGF)-I in Normal Children
por: Nimura, Atsuko, et al.
Publicado: (2004)

Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial
por: Kuppens, R. J., et al.
Publicado: (2016)

Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
por: Alvino, Clair L., et al.
Publicado: (2011)

Does prednisone use in pregnant women with rheumatoid arthritis induce insulin resistance in the offspring?
por: de Steenwinkel, Florentien D. O., et al.
Publicado: (2022)

An Adaptive Multi-Target Radar Waveform Design Based on PWS Algorithm
por: Wang, Bin, et al.
Publicado: (2019)

Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
por: Lee, D. Y., et al.
Publicado: (1999)

Patients with mosaic methylation patterns of the Prader-Willi/Angelman Syndrome critical region exhibit AS-like phenotypes with some PWS features
por: Aypar, Umut, et al.
Publicado: (2016)

Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader–Willi syndrome, Bardet–Biedl syndrome and craniopharyngioma versus anorexia nervosa
por: Vlaardingerbroek, H, et al.
Publicado: (2021)

Identification of insulin-like growth factor (IGF)-I and IGF-binding protein in chylous ascites.
por: Lee, D. Y.
Publicado: (1998)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

Production of immunoreactive insulin-like growth factor-I (IGF-I) and IGF-I binding proteins by human lung tumours.
por: Reeve, J. G., et al.
Publicado: (1990)

Fat mass and fat‐free mass track from infancy to childhood: New insights in body composition programming in early life
por: van Beijsterveldt, Inge A. L. P., et al.
Publicado: (2021)

Immunolocalization of insulin-like growth factor-I (IGF-I) and its receptors (IGF-IR) in the equine epididymis
por: YOON, Minjung, et al.
Publicado: (2014)

PWS/AS MS-MLPA Confirms Maternal Origin of 15q11.2 Microduplication
por: Dawson, Angelika J., et al.
Publicado: (2015)

Analysis and comparisons of gene expression changes in patient- derived neurons from ROHHAD, CCHS, and PWS
por: Victor, A. Kaitlyn, et al.
Publicado: (2023)

Reduced Cortical Complexity in Children with Prader-Willi Syndrome and Its Association with Cognitive Impairment and Developmental Delay
por: Lukoshe, Akvile, et al.
Publicado: (2014)

A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk
por: Allen, N E, et al.
Publicado: (2005)

Human conditions of insulin-like growth factor-I (IGF-I) deficiency
por: Puche, Juan E, et al.
Publicado: (2012)

Leukocyte Telomere Length in Young Adults Born Preterm: Support for Accelerated Biological Ageing
por: Smeets, Carolina C. J., et al.
Publicado: (2015)

Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues.
por: Van der Ven, L. T., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_ehi3tprdunman7egtsk7ef92b2